Genomics
Inside the UK's £650m bet on genomic medicine
The UK government has quietly positioned itself at the front of a race few of its peers are even running.
The UK government has quietly positioned itself at the front of a race few of its peers are even running.
When the FDA approved the first CAR-T therapy for leukaemia in 2017, the assumption across the industry was that the blood cancer playbook would translate quickly into solid tumours. It did not.
The UAE imports roughly 85 per cent of its food. For a country that has made state-capacity industrial policy a signature of its modernisation, that number is not a fact to be accepted — it is a problem to be solved with capital and technology.